mounjaro tirzepatide fda label prescribing information pdf approves new version of diabetes drug to be sold for weight loss Getting started with Mounjaro (Tirzepatide

Description

Whether using prefilled single-use or multi-dose pens, or compounded GLP-1 medications in vials, the medication must be used before its expiration date

Ne pas rutiliser les aiguilles ou les stylos prremplis

This includes physician notes describing medical issues caused by excess skin, photographs showing the severity of skin excess, and records of failed conservative treatments like topical medications or physical therapy

The appetite suppression caused by tirzepatide can make it challenging to meet protein and micronutrient requirements, which is especially problematic for conditions where malnutrition worsens disease outcomes